Ribavirin for hepatitis

Common Questions and Answers about Ribavirin for hepatitis

rebetol

Avatar f tn there are no doctors here. there is medicine that can cure hepatitis C. it is a combo called interferon & ribavirin. in about a year there will be new drugs that when added to the present drugs offer even a better cure for hepatitis c.
Avatar m tn Solvadi is approved for people with genotypes 1 and 4, in combination with interferon and ribavirin. People with genotypes 2 and 3 can use Solvadi with ribavirin alone. That means they will no longer have to take interferon which has many side effects that many people find makes treatment difficult. The wholesale cost of a 12-week course of Olysio, will be about $66,000. The wholesale cost of a 12-week course of Solvadi will be about $84,000.
Avatar f tn //www.medhelp.org/health_pages/Hepatitis/Hepatitis-C-Acronyms-Abbreviations/show/3?
Avatar f tn The standard duration of pegylated interferon/ribavirin alone is 48 weeks for people with genotype 1 and 24 weeks for those with genotypes 2 or 3. NEUTRINO enrolled 327 previously untreated chronic hepatitis C patients with HCV genotypes 1, 4, 5, and 6. These genotypes have traditionally been considered "hard to treat," but as several studies at the congress showed, all may not be equally difficult, just as genotypes 2 and 3 are not equally "easy to treat".
Avatar n tn what do you suggest her now?should she go for pegulated interferon?how is the result of pegulated interferon?
179856 tn?1333547362 Vertex Announces Plans to Enroll Additional Treatment Arm in Ongoing Phase 2 Combination Study of Telaprevir and VX-222 for the Treatment of People with Hepatitis C -New treatment arm to evaluate all oral, triple combination regimen of telaprevir, VX-222, and ribavirin- CAMBRIDGE, Mass., Nov 10, 2010 (BUSINESS WIRE) -- Vertex Pharmaceuticals Incorporated /quotes/comstock/15*!vrtx/quotes/nls/vrtx (VRTX 33.47, -0.63, -1.
Avatar m tn 49 previously untreated participants with genotype 2 or 3 chronic hepatitis C were randomly assigned to receive telaprevir alone (750 mg every 8 hours), telaprevir with pegylated interferon alfa-2a (Pegasys) plus 800 mg ribavirin, or pegylated interferon/ribavirin with placebo for 2 weeks. All participants then received pegylated interferon/ribavirin through week 24 (the standard duration of treatment for these genotypes).
Avatar f tn Bristol-Myers Squibb Announces Acceptance of New Drug Application for Investigational Daclatasvir for FDA Review for the Treatment of Hepatitis C Genotype 3 The NDA contains data to support approval for daclatasvir in combination with sofosbuvir; would be the first 12-week regimen specifically for the treatment of hepatitis C genotype 3 The application is based on a Phase III clinical trial which tested a 12-week, ribavirin-free regimen and resulted in sustained virologic response (SVR12) in
250084 tn?1303307435 //www.medhelp.org/health_pages/Hepatitis/Common-Hepatitis-C-Acronyms/show/3?
Avatar n tn Upon analyzing over 3,000 people being treated for Hepatitis C with pegylated interferon and ribavirin, Mark Sulkowski and colleagues found this to be true even when ribavirin reduction or ESA administration was given to reduce anemia. In fact, the rates of achieving a sustained virological response were greater as the severity of the anemia increased.
4043517 tn?1374006573 http://health.yahoo.net/news/s/nm/fda-approves-glaxo-ligand-platelet-drug-for-hepatitis-c-patients Good news for someone like myself.
476246 tn?1418870914 26June2008 Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.
Avatar f tn 12 POSITRON Demonstrates Efficacy of a 12-Week All-Oral Regimen of Sofosbuvir Plus Ribavirin for Chronic Hepatitis C Patients who are Unable or Unwilling to Take Interferon Gilead Sciences today announced topline results from the Phase 3 POSITRON study examining a 12-week course of once-daily sofosbuvir plus ribavirin (RBV) in patients with genotype 2 or 3 chronic hepatitis C virus (HCV) infection who are not candidates to take interferon (IFN).
Avatar m tn The prescribing information for Epclusa calls for 12 weeks of treatment either alone or with ribavirin.
Avatar m tn 139 The therapeutic mechanisms of ribavirin for hepatitis C are unclear. Microarray analyses have shown that ribavirin increases induction of interferon-stimulated genes. We evaluated viral kinetics, serum cytokine expression, and viral mutagenesis during early stages of peginterferon therapy with and without ribavirin.
5111569 tn?1363753882 It many take a number of years before they are available in Vietnam. Vietnam still uses only Peg-interferon and Ribavirin to treat hepatitis C because of its limited resources. There are two new drugs to choose from. The treatment involves adding one or the other to the drugs you took before. They have been available in the US that are added to the drugs you took (Peg-Interferon and Ribavirin) that are move effective then with just the two drugs.
348159 tn?1233169707 Hep c is treatable. The treatment today is Interferon shots once a week and several Ribavirin pills every day. The length of treatment is either 24 or 48 weeks depending on the Genotype of Hep c that the patient has. There is a lot to do before treatment. The patient needs to go to a specialist either a Gastro or hepatoligist. They will do blood work to determine what type of Hep c and how much damage has been caused. And then they will either recommend for or against treatment.
Avatar m tn com Studies continue to show that adequate doses of ribavirin, which helps to prevent relapse after completion of therapy, are important for optimal treatment of chronic hepatitis C virus (HCV) infection. Hepatitis C is a virus-caused liver inflammation which may cause jaundice, fever and cirrhosis.
Avatar n tn If you are talking about Hepatitis C treatment, Pegasys is NOT given by itself for treatment naive patients. Pegasys is given in conjunction with Ribavirin for Genotype 2 and Genotype 3 patients. Pegasys is given in conjunction with Ribavirin and a Protease Inhibitor (either Incivek or Victrelis) for Genotype 1 patients. "Due to the intensity and major side effects of the Incivek, it has been advised to start with the interferon/ribavirin treatment.
979080 tn?1323433639 This multicentre, randomized, double-blind, placebo-controlled study randomized 50 adult patients with chronic hepatitis C genotype 4 at three centres in Egypt to nitazoxanide 500 mg tablet or placebo twice daily for 24 weeks. Patients were followed up every 4 weeks during treatment and for 24 weeks after therapy. RESULTS: Seven of 23 patients (30.4%) in the nitazoxanide group achieved undetectable serum HCV RNA compared to 0 of 24 in the placebo group during therapy (P = 0.004).